The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant stage III triple negative breast cancer (TNBC): BCT1702—Survival results.
 
Sherene Loi
Honoraria - Mersana; MSD Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Lilly (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Tallac Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - BMS
Other Relationship - Roche Medical writing support
 
Prudence A. Francis
Honoraria - Amplity Health; Lilly
 
Nicholas Zdenkowski
Honoraria - AstraZeneca; Eisai; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; MSD; Novartis
Research Funding - Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Novartis; Roche
 
Val Gebski
No Relationships to Disclose
 
Stephen B. Fox
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Expert Testimony - AstraZeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Thermo Fisher Scientific; Ventana Medical Systems
 
Michelle White
No Relationships to Disclose
 
Belinda Emma Kiely
Honoraria - Eisai; Gilead Sciences; MSD Oncology; Novartis
Consulting or Advisory Role - Gilead Sciences; Novartis; Roche
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pfizer
 
Rina Hui
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Janssen; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); BMSi (Inst); Corvus Pharmaceuticals (Inst); Janssen (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); OncoSec (Inst); Roche (Inst); Seagen (Inst)
 
Andrew David Redfern
No Relationships to Disclose
 
Raewyn Calvert
No Relationships to Disclose
 
Lauren Rennie
No Relationships to Disclose
 
Heath Badger
No Relationships to Disclose
 
Frances M. Boyle
Honoraria - AstraZeneca; Eisai; Gilead Sciences; Lilly; Roche
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Expert Testimony - Gilead Sciences; Lilly
Travel, Accommodations, Expenses - Novartis
Other Relationship - Pamgene; Paxman
(OPTIONAL) Uncompensated Relationships - Paxman; Paxman